1. Home
  2. REPL vs MUI Comparison

REPL vs MUI Comparison

Compare REPL & MUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • MUI
  • Stock Information
  • Founded
  • REPL 2015
  • MUI 2003
  • Country
  • REPL United States
  • MUI United States
  • Employees
  • REPL N/A
  • MUI N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • MUI Investment Bankers/Brokers/Service
  • Sector
  • REPL Health Care
  • MUI Finance
  • Exchange
  • REPL Nasdaq
  • MUI Nasdaq
  • Market Cap
  • REPL 780.3M
  • MUI 915.7M
  • IPO Year
  • REPL 2018
  • MUI N/A
  • Fundamental
  • Price
  • REPL $11.85
  • MUI $12.18
  • Analyst Decision
  • REPL Strong Buy
  • MUI
  • Analyst Count
  • REPL 6
  • MUI 0
  • Target Price
  • REPL $17.50
  • MUI N/A
  • AVG Volume (30 Days)
  • REPL 818.5K
  • MUI 217.1K
  • Earning Date
  • REPL 02-06-2025
  • MUI 01-01-0001
  • Dividend Yield
  • REPL N/A
  • MUI 4.13%
  • EPS Growth
  • REPL N/A
  • MUI N/A
  • EPS
  • REPL N/A
  • MUI N/A
  • Revenue
  • REPL N/A
  • MUI N/A
  • Revenue This Year
  • REPL N/A
  • MUI N/A
  • Revenue Next Year
  • REPL $300.41
  • MUI N/A
  • P/E Ratio
  • REPL N/A
  • MUI N/A
  • Revenue Growth
  • REPL N/A
  • MUI N/A
  • 52 Week Low
  • REPL $4.92
  • MUI $9.73
  • 52 Week High
  • REPL $17.00
  • MUI $12.09
  • Technical
  • Relative Strength Index (RSI)
  • REPL 51.79
  • MUI 43.77
  • Support Level
  • REPL $10.05
  • MUI $12.00
  • Resistance Level
  • REPL $11.20
  • MUI $12.28
  • Average True Range (ATR)
  • REPL 0.92
  • MUI 0.08
  • MACD
  • REPL -0.08
  • MUI 0.01
  • Stochastic Oscillator
  • REPL 51.97
  • MUI 64.29

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About MUI BlackRock Municipal Income Fund Inc.

BlackRock Municipal Income Fund Inc is a diversified investment fund with an investment objective is to provide common shareholders with high current income exempt from U.S. federal income taxes. The company invests in Transportation, Corporate, County/City/Special District/School District, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: